Melatonin: What It Actually Does, Why Most People Take Too Much, and What the Research Shows

Walk into any pharmacy or health food store and you will likely find melatonin supplements in doses of 5 mg, 10 mg, or even 20 mg. These are marketed as sleep aids — the implication being that more melatonin means deeper, longer sleep. But this narrative contains a fundamental misunderstanding of what melatonin actually does in the human body.

The amount of melatonin your pineal gland produces naturally on a healthy night — the amount that coordinates your entire sleep architecture — is typically between 0.1 mg and 0.3 mg (100 to 300 micrograms). Most over-the-counter supplements deliver 10 to 100 times this amount.

This guide explains what melatonin really is, what role it actually plays in sleep, and what human clinical trials show about when supplementation is appropriate and at what doses.

1. What Melatonin Actually Does: The Hormone of Darkness

Melatonin is not a sedative. It does not knock you out, force your brain into slow-wave sleep, or directly induce drowsiness the way a pharmaceutical sleep aid does.

Its biological role is far more subtle and far more important: melatonin is a timing signal. It tells every cell in your body that darkness has arrived — that it is time to shift into nighttime metabolic programs. This distinction matters enormously for understanding both when supplementation is useful and why high-dose supplementation often fails.

As covered in depth in our circadian biology guide, melatonin is synthesized in the pineal gland via a multi-step enzymatic cascade beginning with the amino acid tryptophan:

L-Tryptophan -> 5-HTP -> Serotonin -> N-Acetylserotonin (via AANAT) -> Melatonin (via HIOMT)

The rate-limiting enzyme in this process, AANAT (arylalkylamine N-acetyltransferase), is activated by darkness signals from the SCN. When blue light (460–480 nm) strikes the retina — even at low intensities — the SCN transmits inhibitory signals that degrade AANAT within minutes, halting melatonin synthesis.

This is why evening blue light exposure is one of the most powerful disruptors of natural melatonin release, and why dimming your environment matters far more for sleep than any melatonin supplement.

2. The Melatonin Receptor System: How It Signals the Body

Melatonin exerts its effects through two primary G-protein coupled receptors:

MT1 Receptors

Highly concentrated in the SCN itself, MT1 receptors mediate melatonin's acute sleep-promoting effects. When melatonin binds MT1 receptors in the SCN, it inhibits the SCN's firing rate — essentially quieting the master clock's wakefulness signaling. This contributes to reduced alertness and facilitates the shift into sleep readiness.

MT1 receptors also regulate peripheral circadian clocks in the pancreas, liver, and cardiovascular system, helping coordinate nighttime metabolic programs (such as reduced insulin sensitivity and reduced cardiovascular demand).

MT2 Receptors

MT2 receptors are primarily involved in circadian phase shifting. Melatonin binding at MT2 receptors in the early evening helps advance the circadian clock (shift it earlier), while binding in the early morning helps delay it. This is the mechanism underlying melatonin's utility as a circadian phase-shifting tool — which is its most evidence-supported clinical use.

3. The Natural Melatonin Curve

Understanding the natural secretion profile of melatonin is essential to evaluating supplementation strategies.

 Melatonin Level (Rough Illustration)

 High |                    ___________
      |                  /            \
      |                /               \
 Mid  |              /                  \
      |            /                     \
 Low  |__________/                        \__________
      6 AM    Noon    6 PM   10 PM   2 AM   4 AM   6 AM
               (Dim onset: ~9 PM)  (Peak: 2–4 AM)

• Dim-Light Melatonin Onset (DLMO): In a healthy adult in a light-managed environment, melatonin secretion begins approximately 2 hours before habitual sleep time. This is called the Dim-Light Melatonin Onset (DLMO) and is considered the most accurate biomarker of circadian phase.
• Peak Secretion: Melatonin peaks between 2:00 AM and 4:00 AM, reaching blood concentrations of 80–200 picograms per milliliter.
• Morning Suppression: As morning light enters the retina, SCN signals suppress AANAT activity and melatonin concentrations fall rapidly.

4. The Dosing Controversy: Why Less is More

This is where the evidence diverges sharply from common practice.

What Human Trials Show About Dose

A landmark series of studies from the Massachusetts Institute of Technology (MIT) evaluated the pharmacokinetics of melatonin at multiple doses. Key findings:

• Physiological Dose (0.1–0.3 mg): Produces blood melatonin concentrations within the normal nighttime physiological range (40–200 pg/mL). Associated with improved sleep onset latency without next-day drowsiness.
• Low-Range Supplemental Dose (0.5–1.0 mg): Raises blood melatonin to supraphysiological levels (500–1,000 pg/mL) — several times above the natural peak. Still associated with sleep onset improvements, modest phase-shifting effects.
• High Supplemental Dose (5–10 mg): Raises blood melatonin to 2,000–8,000 pg/mL — 10 to 40 times the normal nighttime peak. Evidence for enhanced sleep quality over physiological doses is weak; morning drowsiness increases. Receptor desensitization with chronic high-dose use is a theoretical concern.

Why the Market Sells High Doses

The prevalence of 5 mg and 10 mg products has more to do with manufacturing economics and historical supplement marketing conventions than with clinical dose optimization. Larger doses are easier to tablet and easier to market as "stronger."

The research consistently suggests that 0.3 mg to 1.0 mg is sufficient for sleep onset support in most adults without circadian disruption. Doses above 1 mg provide diminishing returns for sleep quality.

5. When Melatonin IS and IS NOT the Right Tool

When Melatonin IS Appropriate

Circadian Phase Disorders (Jet Lag, Shift Work): This is the most robustly supported use. Low-dose melatonin (0.5–1 mg) taken at the target local bedtime helps shift the circadian clock to the new time zone. Studies show it reduces jet lag symptoms and shortens adaptation time. For shift workers rotating to night shifts, small doses of melatonin taken at strategic times during the day (when they need to sleep) can support daytime sleep.

Delayed Sleep Phase Disorder (DSPD): Individuals with DSPD have circadian clocks running several hours later than conventional society demands. Clinical research supports low-dose melatonin (0.5 mg) taken 5–6 hours before desired sleep time to gradually advance the phase.

Short-Term Sleep Onset Difficulty: For adults experiencing temporary sleep onset difficulties (travel, unusual stress, disrupted schedule), low-dose melatonin (0.5–1 mg) taken 30–60 minutes before bed can shorten sleep onset latency.

When Melatonin IS NOT the Right Tool

Primary Insomnia (Difficulty Staying Asleep): Melatonin addresses sleep onset (difficulty falling asleep) by supporting the timing signal. It has minimal evidence for improving sleep maintenance (staying asleep through the night). If your primary concern is frequent nighttime awakenings, melatonin is unlikely to be the correct intervention.

Chronic Sleep Deprivation From Poor Hygiene: If your sleep problems stem from excessive caffeine, evening blue light, an overheated bedroom, or high stress cortisol, melatonin supplementation addresses none of these underlying causes. Fixing the sleep environment and daily habits (as covered in our sleep hygiene guide) will produce far larger improvements.

Daily Dependency Use: Melatonin is not intended for nightly use as a long-term sleep aid. Unlike prescription sleep aids that suppress the body's own melatonin pathways, melatonin supplementation does not appear to suppress endogenous production at low doses. However, it is best used strategically (for circadian disruption events) rather than habitually.

6. Distinguishing the Evidence: Science vs. Marketing Claims

• Established Evidence: Melatonin is a circadian timing signal, not a sedative. Low doses (0.3–1 mg) support sleep onset latency and circadian phase shifting. Melatonin is most effective for jet lag and delayed sleep phase disorder.
• Moderate Evidence: Melatonin may support sleep in older adults, who experience significantly reduced endogenous melatonin production after age 55.
• Weak Evidence: High-dose melatonin (5–10 mg) producing superior sleep quality over physiological doses in healthy adults is not supported by current clinical research.
• Traditional Use: Melatonin supplements have been used since the early 1990s as jet lag remedies, which aligns closely with its actual biological mechanism.

7. Practical Guidance for Melatonin Use

Based on the available evidence, here is a practical framework for using melatonin appropriately:

• Target Dose: 0.3 mg to 1.0 mg for most adults. Start at 0.3 mg and increase to 1 mg only if needed.
• Timing: Take 30 to 60 minutes before your target sleep time.
• Form: Liquid or sublingual (under-the-tongue) formulations may provide faster absorption than capsules. Immediate-release formulations are appropriate for sleep onset; extended-release versions are sometimes used for sleep maintenance, though the evidence is limited.
• Sourcing: Melatonin supplement accuracy varies widely. Third-party testing studies have found that actual melatonin content ranges from 83% below to 478% above the labeled dose across commercial products. Choose brands with independent certificate of analysis (COA) documentation.
• Do Not Use As A Substitute For Good Sleep Hygiene: Protecting your natural melatonin curve through evening light management and circadian entrainment is far more effective than supplementing with exogenous melatonin.

This guide is for educational purposes only. Readers should consult qualified healthcare professionals before starting, altering, or combining any supplement routine.